Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Soulard
Psy105 - Cost-Utility of Nintedanib Versus Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis: A Belgian Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Evaluating the Annual Cost Per Response Rate of Pirfenidone and Nintedanib for the Treatment of Patients With Idiopathic Pulmonary Fibrosis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Idiopathic Pulmonary Fibrosis and Pirfenidone
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis: Nationwide Danish Results
European Clinical Respiratory Journal
Prs41 - Cost-Effectiveness of Pirfenidone for the Treatment of Patients With Mild to Moderate Idiopathic Pulmonary Fibrosis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Remarkable Improvement in a Patient With Idiopathic Pulmonary Fibrosis After Treatment With Nintedanib
Internal Medicine
Internal Medicine
Medicine
Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
Annals of Thoracic Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Efficacy of Pirfenidone in Patients With Advanced-Stage Idiopathic Pulmonary Fibrosis
Internal Medicine
Internal Medicine
Medicine
Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
Utility of a Lung Biopsy for the Diagnosis of Idiopathic Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
